With the Centers for Medicare and Medicaid Services (CMS) developing a proposal that would force drugmakers to include a drug's list price in direct-to-consumer TV ads, there remains some skepticism about the impact of such a rule.
According to a Wall Street Journal report, consumers have expressed broad support for the rule, with 88 percent saying in a Kaiser Family Foundation survey they want to see list prices in ads. Drugmakers, however, are concerned that displaying only list prices would fail to give consumers accurate pricing information, and have instead suggested referring viewers to a website with more in-depth information.
To read more on the Wall Street Journal, click here.
